Race, education and training A certified urologist and a specialist in the diagnosis and treatment of urological diseases, kidney cancers, bladder and prostate, Dr. David B. Samadi performs many minimally invasive treatments for advanced prostate cancer, including laparoscopic radical prostatectomy and laparoscopic robotic radical prostatectomy. Currently, David B. Samadi, MD is the head of the Robotic and Minimally Invasive Surgery at the School of Medicine, Mount Sinai in New York. He is one of the very few urologic surgeons in the United States trained in surgical oncology, open, laparoscopic, and robotic. He is one of the few surgeons in the State of New York qualified to perform a robotic prostatectomy using the Da Vinci robotic system. Dr. Samadi is the first surgeon in the United States to successfully perform robotic surgery again.He has consistently demonstrated his mastery of the Da Vinci Surgical System and medically proven ability to help patients with low and high risk of prostate cancer. Since his arrival at the School of Medicine at Mount Sinai Hospital in May 2007, Dr. Samadi has performed over 850 successful robotic prostatectomy surgeries, averaging 40-50 new cases per month. Moreover, during the past 7 years, Dr. Samadi also trains and supervises urologists across the country and internationally. Dr. Samadi completed his postgraduate training in general surgery at Montefiore Medical Center and in urology at Albert Einstein College of Medicine and Montefiore Medical Center. He completed his fellowship in urologic oncology at the Cancer Center Memorial Sloan Kettering, of which he is certified in urologic oncology. He completed a fellowship in robotic radical prostatectomy for Henri Mondor Hospital Creteil in France under the mentorship of Professor Claud Abbou.Samadi is fellowship trained in laparoscopic and robotic prostatectomy surgery under Professor Abbou, an internationally recognized expert in both fields.